NCT04907032View on ClinicalTrials.gov

Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

April 15, 2023

Conditions
Overactive Bladder
Interventions
DRUG

Mirabegron 50 MG

Posterior Tibial Nerve Stimulation with Mirabegron vs. Posterior Tibial Nerve Stimulation Plus Placebo

DEVICE

Posterior Tibial Nerve Stimulation (PTNS)

Posterior Tibial Nerve Stimulation with Mirabegron vs. Posterior Tibial Nerve Stimulation Plus Placebo

Trial Locations (1)

35249

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT04907032 - Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study) | Biotech Hunter | Biotech Hunter